AstraZeneca will withdraw its COVID-19 vaccine from the market due to a rare side effect. The disease has been linked to at least 81 deaths in the United Kingdom.

The Oxford-AstraZeneca Covid-19 vaccine is being withdrawn from the market around the world, months after the pharmaceutical company admitted for the first time in court papers that the vaccine may cause a rare and dangerous side effect that in turn causes blood clots and low blood pressure. platelet count. The documents indicate that in very rare cases it can cause thrombosis.

In accordance with Telegraph, who broke the news, the vaccine can no longer be used in the European Union after the company voluntarily revoked its “marketing authorization.” The vaccine recall request was made on March 5 and took effect on Tuesday. In the coming months, similar applications will be filed in the UK and other countries that have approved the vaccine, known as Vaxevria.

TO CMA representative of the pharmaceutical company, on the other hand, assured that the recall of the vaccine was “due to commercial reasons.” “With the development of multiple COVID-19 vaccines, there is a glut of updated vaccines available. This has led to reduced demand for Vaxzervria, which is no longer produced or supplied,” AstraZeneca added in the note, which places patient safety as its “top priority.”